Olema Oncology, Inc. (OLMA) stock
OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.02−0.13 (-1.82%)
Close on Nov 20, 2026Market cap $614.23MP/E –Yield –
Olema Oncology free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Olema Oncology's free cash flow for the twelve months ending Dec 31, 2024 was -$104.51M. For fiscal 2024 it was -$104.51M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$104.51M | – |
| FY2022 | Dec 31, 2022 | -$82.43M | – |
| FY2021 | Dec 31, 2021 | -$52.27M | – |
| FY2020 | Dec 31, 2020 | -$19.92M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -$34.53M | – |
| Q4 FY2024 | Dec 31, 2024 | -$26.28M | – |
| Q3 FY2024 | Sep 30, 2024 | -$27.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$27.56M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$19.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.13M | – |
| Q2 FY2022 | Jun 30, 2022 | -$26.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.93M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.30M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.19M | – |
| Q2 FY2021 | Jun 30, 2021 | -$9.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.50M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.53M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.19M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.15M | – |
See a number that looks wrong?